Definitive Contract 75N95024C00010
Award Date 5/20/24
Potential Completion Date 5/19/26
Potential Value $2M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- Biosensics LLC has been awarded a $325,000 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct research and development activities aligned with the agency's goals. Specifically, the contract calls for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, as outlined in NIH and CDC Solicitation A Solicitation of the National Institutes of...
- This federal contract award to Biosensics LLC is a STTR Phase I contract with a ceiling value of $149,997.80. The contract was awarded by the U.S. Army Medical Command, a defense agency, and is designated as a total small business set-aside. The contract is for research and development work related to developing innovative wearable sensor platforms, cloud-based software solutions, and remote monitoring technologies for healthcare applications. Biosensics LLC is a small business that...
- Nirsense, Inc., a Richmond, Virginia-based small disadvantaged business specializing in advanced wearable sensor systems for physiological monitoring, was awarded a $600,000 firm fixed-price definitive contract by the National Institutes of Health on March 2, 2026. The contract is designated as a Total Small Business set aside and carries an ultimate completion date of March 1, 2027. Nirsense's core competency in near-infrared spectroscopy (NIRS) and multimodal sensor technologies positions...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Advanced Silicon Group, Inc., a woman-owned small business. The contract, valued at $400,000.00, is for research and development of a biosensor prototype that can detect drugs in postmortem blood samples using coupled acoustical wave micropillar technology. The contract is a firm fixed-price definitive contract with a completion date of...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Biosono Inc., a minority-owned for-profit business. The contract is for the development of a biosensor-based core needle tumor biopsy device, under SBIR Topic 331. The fixed-price contract has a ceiling value of $224,961 and a completion date of September 11, 2015. As an SBIR Phase I contract, this represents early-stage research and development work to potentially...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to APDM, Inc., a for-profit manufacturer of digital health and wearable sensor technologies. The contract, valued at $1,457,589.00, is for the development of a wearable system to assess fall risk associated with cancer treatment. As an SBIR Phase II contract, this effort builds upon prior Phase I work. The contract has a...
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Biosensics LLC, a small business located in Newtonville, Massachusetts. The contract is for the development of an automated screening platform to enable early identification of malnutrition in cancer patients. This contract award is part of the FY24 SBIR solicitation, which covers a variety of research topics...
- The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a Small Business Innovation Research (SBIR) Phase I contract to (Ad)2 Technologies, a woman-owned small business, for a wearable alcohol biosensor that quantifies blood alcohol content (BAC) in real-time. The firm-fixed-price contract has a potential value of $499,997.00 and a completion date of July 24, 2020. The SBIR program supports research and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,759 Firm Fixed Price contract to Litmus Health, Inc., a small business, to develop an extensible and scalable platform for data integration from wearable sensors to generate novel analytics for cancer patients. This award is associated with the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS...